THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $208,000 | +2.5% | 11,718 | +21.2% | 0.05% | -34.3% |
| Q2 2020 | $203,000 | -1.9% | 9,672 | +7.9% | 0.07% | -15.7% |
| Q1 2020 | $207,000 | -4.6% | 8,962 | -19.6% | 0.08% | 0.0% |
| Q3 2019 | $217,000 | +29.9% | 11,147 | +9.2% | 0.08% | +18.6% |
| Q2 2019 | $167,000 | +198.2% | 10,205 | +407.0% | 0.07% | +45.8% |
| Q4 2017 | $56,000 | – | 2,013 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $78,677,176 | 13.94% |
| Irenic Capital Management LP | 1,700,937 | $19,084,513 | 9.15% |
| Weiss Asset Management LP | 7,457,060 | $83,668,213 | 3.41% |
| Newtyn Management, LLC | 1,450,000 | $16,269,000 | 3.36% |
| Palliser Capital (UK) Ltd | 97,100 | $1,089,462 | 2.65% |
| Chescapmanager LLC | 850,988 | $9,548 | 2.24% |
| Park West Asset Management LLC | 1,920,324 | $21,546,035 | 2.11% |
| Baupost Group | 11,419,226 | $128,124 | 2.09% |
| Saturn V Capital Management LP | 141,339 | $1,334,342 | 1.11% |
| Oasis Management Co Ltd. | 296,960 | $3,331,891 | 0.66% |